Abenacianine

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameAbenacianine
Drug Alias NameVGT-309
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiagnostic imaging enhancersCathepsins binders
TargetsCathepsins
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVergent Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesVergent Bioscience Inc
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A